Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

Nature Communications

Volumn 6, Issue , 2015, Pages

  De Mattos Arruda, Leticia ^a,b,c   Mayor, Regina ^a   Ng, Charlotte K Y ^b   Weigelt, Britta ^b   Martínez Ricarte, Francisco ^c,d   Torrejon, Davis ^a   Oliveira, Mafalda ^a   Arias, Alexandra ^a   Raventos, Carolina ^a   Tang, Jiabin ^b   Guerini Rocco, Elena ^d   Martínez Saéz, Elena ^d   Lois, Sergio ^d   Marín, Oscar ^d   De La Cruz, Xavier ^d,e   Piscuoglio, Salvatore ^b   Towers, Russel ^b   Vivancos, Ana ^a   Peg, Vicente ^d   Cajal, Santiago Ramon Y ^c,d   Carles, Joan ^a   Rodon, Jordi ^a   González Cao, Mariá ^f   Tabernero, Josep ^a,c   Felip, Enriqueta ^a,c   Sahuquillo, Joan ^c,d   Berger, Michael F ^b   Cortes, Javier ^a,c   Reis Filho, Jorge S ^b   Seoane, Joan ^a,c,e   more..

^a VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^f INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FREE CIRCULATING TUMOUR DNA; DNA; UNCLASSIFIED DRUG;

BIOMARKER; BODY FLUID; BRAIN; DNA; GENOMICS; MUTATION; NERVOUS SYSTEM; PLASMA; TUMOR;

ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; BREAST METASTASIS; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; PLASMA; SENSITIVITY ANALYSIS; SOMATIC MUTATION; BLOOD; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; GLIOBLASTOMA; LUNG TUMOR; MEDULLOBLASTOMA; MENINGIOMA; PATHOLOGY; PHYSIOLOGY; SECONDARY;

BRAIN NEOPLASMS; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; GLIOBLASTOMA; HUMANS; LUNG NEOPLASMS; MEDULLOBLASTOMA; MENINGEAL NEOPLASMS;

EID: 84946719441     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9839     Document Type: Article

References (26)

1. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
2. Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. USA 110, 4009-4014 (2013).
3. Omuro, A., DeAngelis, L. M. Glioblastoma and other malignant gliomas: a clinical review. JAMA 310, 1842-1850 (2013).
4. Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108-112 (2013).
5. Dawson, S. J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199-1209 (2013).
6. De Mattos-Arruda, L. et al. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-ofprinciple. Ann. Oncol. 25, 1729-1735 (2014).
7. Bettegowda, C. et al. Detection of circulating tumor DNA in early-and late-stage human malignancies. Sci. Transl. Med. 6, 224ra24 (2014).
8. Segal, M. B. Extracellular and cerebrospinal fluids. J. Inherit. Metab. Dis. 16, 617-638 (1993).
9. Pan, W., Gu, W., Nagpal, S., Gephart, M. H., Quake, S. R. Brain tumor mutations detected in cerebral spinal fluid. Clin. Chem. 61, 514-522 (2015).
10. Cheng, D. T. et al. Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J. Mol. Diagn. 17, 251-264 (2015).
11. Brastianos, P. K. et al. Genomic characterization of brain metastasis reveals branched evolution and potential therapeutic targets. Cancer Discov. 5, 1-14 (2015).
12. Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189-193 (2014).
13. Ding, L. et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464, 999-1005 (2010).
14. Saunus, J. M. et al. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance. J. Pathol. 237, 363-378 (2015).
15. Paik, P. K. et al. Next-generation sequencing of stage IV squamous cell lung cancers reveals an association of PI3K aberrations and evidence of clonal heterogeneity in patients with brain metastases. Cancer Discov. 5, 610-621 (2015).
16. Hernandez, L. et al. Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection. J. Pathol. 227, 42-52 (2012).
17. Won, H. H., Scott, S. N., Brannon, A. R., Shah, R. H., Berger, M. F. Detecting somatic genetic alterations in tumor specimens by exon capture and massively parallel sequencing. J. Vis. Exp. 80, e50710 (2013).
18. Natrajan, R. et al. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J. Pathol. 232, 553-565 (2014).
19. Li, H., Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
20. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
21. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013).
22. Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811-1817 (2012).
23. Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568-576 (2012).
24. Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24-26 (2011).
25. Lamble, S. et al. Improved workflows for high throughput library preparation using the transposome-based Nextera system. BMC Biotechnol. 13, 104 (2013).
26. Forshew, T. et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, 136ra68 (2012).